Research Overview: Primobolan tabs Pharmaceutical
Primobolan pharmaceutical tablets are formulated with methenolone acetate, a C17-acetate ester derivative of dihydrotestosterone (DHT). This oral anabolic steroid compound exhibits unique molecular properties that make it valuable for laboratory research investigating androgen receptor interactions and anabolic pathway mechanisms. Researchers at Stroid UK Shop examine this compound’s selective tissue binding characteristics and its role in protein synthesis studies. The pharmaceutical-grade formulation ensures consistent molecular integrity for reliable experimental outcomes in steroid biochemistry research.
Laboratory Applications
Scientists investigate methenolone acetate’s distinctive properties in comparative anabolic steroid studies, particularly its reduced hepatotoxicity profile compared to other oral compounds. Research applications include examining its interaction with androgen receptors across different tissue types, studying its metabolic pathways through cytochrome P450 enzymes, and analysing its molecular stability under various laboratory conditions. The compound’s oral bioavailability characteristics make it suitable for pharmacokinetic studies, while its mild androgenic profile provides researchers with unique experimental parameters. Laboratories studying methenolone acetate compounds often compare its molecular behaviour against other research chemicals including selective androgen receptor modulators and peptide compounds to understand tissue-selective anabolic mechanisms.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 17β-Hydroxy-1-methyl-5α-androst-1-en-3-one acetate |
| CAS Number | 434-05-9 |
| Molecular Formula | C₂₂H₃₂O₃ |
| Molecular Weight | 344.49 g/mol |
| Form | Oral tablets |
| Storage Conditions | Room temperature, dry environment |
| Stability | Stable under normal laboratory conditions |
| Solubility | Limited water solubility, organic solvent compatible |
Research Compliance
These Primobolan pharmaceutical tablets are supplied exclusively for in-vitro research purposes and laboratory analytical studies. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure proper handling protocols, maintain appropriate storage conditions, and follow institutional safety guidelines when conducting studies with this compound. All experimental work should be performed by qualified personnel in appropriately equipped laboratory facilities with proper ventilation and safety measures in place.
